Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Attention Deficit and Hyperactivity Disorder (ADHD) is linked to dopamine pathway dysregulation.
• Synapsin III (Syn III) gene variations may influence ADHD susceptibility and methylphenidate (MPH) treatment efficacy.
• MPH's action is associated with brain-derived neurotrophic factor (BDNF), and MPH binds Syn III, suggesting a role in neuronal development.

Purpose of the Study:

• To investigate the role of Syn III in the early development of dopaminergic neurons.
• To determine if Syn III's function in dopaminergic neuron development is conserved across species.
• To elucidate the molecular mechanisms by which Syn III influences dopaminergic neuron development, particularly its relationship with BDNF and Cdk5.

Main Methods:

• Utilized zebrafish embryos with Syn III gene knockdown (KD).
• Studied Syn III knockout (ko) mice.
• Employed human induced pluripotent stem cells (iPSCs)-derived neurons with Syn III RNA interference.

Main Results:

• Syn III plays a fundamental role in the initial stages of dopaminergic neuron development, a conserved function across vertebrates.
• In mammals, Syn III acts upstream of BDNF and Cdk5 signaling pathways, regulating dendrite development.
• Syn III's involvement in dopaminergic neuron development provides a potential link between genetic variations and ADHD.

Conclusions:

• Syn III is essential for the early development of dopaminergic neurons.
• The findings suggest Syn III's role in ADHD pathogenesis and MPH response is mediated through BDNF-dependent dopaminergic neuron development.
• This research provides significant insights into the biological underpinnings of ADHD.